LTX-315 triggers anticancer immunity by inducing MyD88-dependent maturation of dendritic cells
LTX-315 is a synthetic cationic oncolytic peptide with potent anticancer activity but limited toxicity for non-malignant cells. LTX-315 induces both immunogenic tumor cell death and generation of tumor-specific immune responses in multiple experimental…